Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Cash from Investing Activities (2020 - 2025)

Ovid Therapeutics' Cash from Investing Activities history spans 6 years, with the latest figure at -$72.1 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 438.45% year-over-year to -$72.1 million; the TTM value through Dec 2025 reached -$49.9 million, down 191.32%, while the annual FY2025 figure was -$49.9 million, 191.32% down from the prior year.
  • Cash from Investing Activities reached -$72.1 million in Q4 2025 per OVID's latest filing, down from $5.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $30.2 million in Q1 2023 to a low of -$80.7 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$4.4 million, with a median of -$37774.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: plummeted 9246.58% in 2022, then surged 2908.96% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$161958.0 in 2021, then crashed by 2474.44% to -$4.2 million in 2022, then crashed by 1063.59% to -$48.5 million in 2023, then soared by 143.89% to $21.3 million in 2024, then plummeted by 438.45% to -$72.1 million in 2025.
  • Per Business Quant, the three most recent readings for OVID's Cash from Investing Activities are -$72.1 million (Q4 2025), $5.1 million (Q3 2025), and $12.1 million (Q2 2025).